Skip to content

FDA Regulatory News

Latest regulatory updates, standard revisions, and guidance publications in the medical device compliance space.

FDA Class I Recall: Insulet Removes Omnipod Pods Insulin Pump Due to Under-Delivery Risk

2026-07-03 | FDA | cdrh_news | !!! HIGH

The FDA has announced a Class I recall for Insulet's Omnipod Pods, used with the Omnipod DASH Insulin Management System, due to a missing cannula or needle that can result in under-delivery of insulin. This poses risks of hyperglycemia, diabetic ketoacidosis, and death. Patients and caregivers must immediately stop using affected lots, contact Insulet for replacements, and transition to an alternative insulin delivery method.

Tags: insulin_pump, class_I_recall, omnipod, diabetes_device, safety_alert, insulet

View Source (FDA)


Abiomed Recalls Impella CP Sets with SmartAssist Due to Potential for Catheter Perforation

2026-07-03 | FDA | cdrh_news | !!! HIGH

Abiomed is recalling its Impella CP with SmartAssist sets after reports of the catheter tip breaking or perforating during insertion, which could lead to serious injury or death. The FDA has classified this as a Class I recall, the most serious type. Health care providers should immediately stop using affected devices and follow Abiomed's instructions for return and replacement. The recall affects certain lots distributed from August 2021 to March 2023.

Tags: recall, class_i, impella_cp, smartassist, heart_pump, abiomed, catheter_perforation

View Source (FDA)


Class I Recall: Abiomed, Inc. - Abiomed Impella CP Set with SmartAssist (10th Generation) containing affected 14

2026-07-01 | FDA | recall_class1 | !!! HIGH

Abiomed, Inc. is recalling 168 units of its Impella CP Set with SmartAssist (10th Generation) that contain the affected component 14. The recall was initiated due to the potential for thrombus formation during prolonged use of the introducer. Customers should immediately locate and quarantine the affected sets, discontinue use, and return them to Abiomed as instructed in the firm's Urgent Medical Device Recall notice.

Tags: class_i_recall, abiomed, impella_cp, thrombus, introducer

View Source (FDA CDRH)


Abiomed Recalls Impella CP Low Profile Introducer Kit Due to Thrombus Risk – FDA Class I Recall

2026-07-01 | FDA | recall_class1 | !!! HIGH

Abiomed, Inc. has initiated a Class I recall of its Abiomed 14 Fr x 25 cm Low Profile Introducer Kit for Impella CP, part of the Impella Set Pro, due to the potential for thrombus formation during prolonged use. The FDA has classified this as the most serious type of recall, indicating a risk of serious injury or death. A total of 17 units are affected. Healthcare providers should immediately stop using the recalled devices, quarantine them, and contact Abiomed for return instructions.

Tags: fda_class_i_recall, abiomed, impella_cp, introducer_kit, thrombus_risk, medical_device

View Source (FDA CDRH)


Class I Recall: Abiomed 14 Fr Low Profile Introducer Kit for Impella CP – Thrombus Formation Risk

2026-07-01 | FDA | recall_class1 | !!! HIGH

Abiomed, Inc. is recalling its 14 Fr x 13 cm Low Profile Introducer Kit (used with Impella CP/Impella Set Pro) due to a potential for thrombus formation during prolonged use. This Class I recall, the most serious type, involves only 3 units. Users should immediately quarantine the affected kits and follow the manufacturer’s instructions to prevent possible embolic events.

Tags: class_i_recall, thrombus_formation, impella_cp, abiomed, introducer_kit

View Source (FDA CDRH)


Class I Recall: Medline Industries, LP - Medline Convenience Kits: 1) DYNJ905503F, Model Number: CV ANESTHESIA - ROOM

2026-07-01 | FDA | recall_class1 | !! MEDIUM

Recall #Z-2452-2026 by Medline Industries, LP. Reason: The Medline Convenience Kits contain Arrow Kits and Sets that include Lidocaine Hydrochloride Injection, USP and Bupivacaine Hydrochloride in Dextrose Injection, USP which were recalled due to quality. Quantity: 227 units.

View Source (FDA CDRH)


FDA Title 21 CFR Update: Medical Device Parts 800-898 Revised (June 26, 2026)

2026-06-30 | FDA | Regulation Update | !! MEDIUM

The FDA has updated Title 21 of the Code of Federal Regulations (CFR), with the latest revision dated June 26, 2026. This update potentially affects medical device regulations under Parts 800-898. Regulatory affairs professionals should review the amended sections to ensure ongoing compliance for medical device manufacturing, labeling, and quality systems.

Tags: fda, cfr_title_21, medical_device_regulations

View Source (eCFR)


Accuray CyberKnife Xchange Collimator Changer Recalled: Collimator Docking Failure May Cause Injury

2026-06-16 | FDA | Safety Communication | !!! HIGH

Accuray Incorporated is recalling its CyberKnife Treatment Delivery System with Xchange Robotic Collimator Changer due to a risk that a collimator may not fully dock. If personnel enter the treatment room and use the in-room control pendant after a docking interlock, the collimator could fall, posing a serious injury hazard. Users must follow the manufacturer's corrective actions, including not attempting manual motion when the interlock is active.

Tags: recall, radiation_therapy, collimator, safety, linear_accelerator, medical_device

View Source (FDA CDRH)


Accuray CyberKnife with Xchange Collimator Changer Recalled for Collimator Docking Failure Hazard

2026-06-16 | FDA | Safety Communication | !!! HIGH

The FDA announced a recall of Accuray's CyberKnife Treatment Delivery System equipped with the Xchange Robotic Collimator Changer. If a collimator does not fully dock, a system interlock may be triggered; should personnel then manually move the robot using the in-room pendant, the collimator could fall, risking injury to patients or staff. Users should immediately inform all operators of this risk and adhere to the manufacturer's interim safety instructions until a permanent correction is deployed.

Tags: device_recall, radiation_oncology, collimator_failure, patient_safety, fda_recall

View Source (FDA CDRH)


Recall: Zimmer Surgical Sterile Tourniquet Hoses (A.T.S 4000 TS) – Potential Sterility Breach (Recall Z-2673-2026)

2026-06-09 | FDA | Safety Communication | !!! HIGH

Zimmer Surgical has initiated a recall (Z-2673-2026) of its A.T.S 4000 TS Tourniquet Systems Dual Hose with CPC Connectors due to a potential sterility breach in the sealing area of the sterile pouch. Use of affected devices could lead to moderate localized infection requiring treatment; if the issue is noticed before use, it may cause a clinically insignificant delay while an alternative device is obtained. Healthcare providers should immediately identify and quarantine all affected units, stop using them, and return them to the manufacturer as instructed.

Tags: device_recall, sterility_breach, tourniquet_hoses, zimmer_surgical

View Source (FDA CDRH)


Zimmer Surgical Recalls A.T.S 4000 TS Tourniquet Single Hose Over Potential Sterility Breach

2026-06-09 | FDA | Safety Communication | !!! HIGH

The FDA has announced a recall of Zimmer Surgical's A.T.S 4000 TS Tourniquet Systems Single Hose with CPC Connectors (Recall Z-2674-2026) due to a potential sterility breach in the sealing area of the sterile pouch. If the affected device is used, it may lead to moderate localized infection; if discovered prior to use, it may cause a clinically insignificant extension of surgery while an alternative is sourced. Healthcare providers should immediately identify and quarantine all affected units.

Tags: recall, sterility_breach, tourniquet_hose, zimmer_surgical, infection_risk

View Source (FDA CDRH)


FDA Recalls Siemens ARTIS icono ceiling Due to Risk of Monitor Detachment from Ceiling Suspension

2026-06-08 | FDA | Safety Communication | !!! HIGH

The FDA has issued a Class I recall (Z-2648-2026) for the Siemens ARTIS icono ceiling angiography system (model 11328100) due to a potential issue with the Display Ceiling Suspension (DCS Fix XL). Over time, screws securing the monitor to the suspension may gradually loosen, causing the monitor to detach and fall, posing a risk of impact injury to patients or healthcare staff. Affected facilities should immediately inspect the suspension assembly and contact Siemens to arrange for corrective maintenance.

Tags: fda_recall, siemens_medical_solutions, artis_icono_ceiling, ceiling_suspension, loose_screws, safety_alert

View Source (FDA CDRH)


Medela Recalls ENFit ExSet Syringes Due to Incompatible Connectors Risking Enteral Feeding Delays

2026-06-05 | FDA | Safety Communication | !!! HIGH

Medela Inc. is recalling its ENFit ExSet Strl 60 2.0ml PV 1ct EN syringe (Model ENF060182LD / 101033086) because the product may contain incorrect connectors that cannot attach or misconnect to ENFit connections. This incompatibility could cause a slight delay in the delivery of enteral nutritional fluids or oral medication. Healthcare providers and patients should immediately identify affected units, discontinue use, and follow the firm's instructions for return or disposal.

Tags: recall, enteral_feeding, connector_safety, fda, medela

View Source (FDA CDRH)


Device Recall: Remel, Inc - GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460

2026-06-03 | FDA | Safety Communication | !! MEDIUM

Recall Z-2623-2026: Reduced or no recovery of some strains of Neisseria gonorrhoeae.

View Source (FDA CDRH)


FDA Revised Cybersecurity Guidance for Medical Devices (Feb 2026)

2026-02-03 | FDA | New Guidance | !!! HIGH

Issued 3 February 2026, superseding the June 2025 version. Aligns with the new QMSR and ISO 13485. Applies to all devices with cybersecurity considerations, not just network-connected devices. Key expectations: Secure Product Development Framework (SPDF), threat modeling, Software Bill of Materials (SBOM), eight security control categories (authentication, authorization, cryptography, integrity, confidentiality, event detection, resiliency, updatability), and coordinated vulnerability disclosure processes.

Tags: cybersecurity, premarket_submission, software, sbom

View Source (FDA)


QMSR Takes Effect -- 21 CFR Part 820 Incorporates ISO 13485:2016

2026-02-02 | FDA | Regulation Update | !!! HIGH

Effective 2 February 2026, the FDA's Quality Management System Regulation (QMSR) amends 21 CFR Part 820 by incorporating ISO 13485:2016 by reference. The legacy Quality System Inspection Technique (QSIT) was discontinued and replaced by Compliance Program 7382.850, aligned with ISO 13485. Manufacturers must now explicitly comply with ISO 13485:2016 requirements. Two older guidance documents (1997 design control guidance and 2008 PMA manufacturing inspection guidance) were withdrawn.

Tags: quality_management, iso_13485, cgmp, inspection

View Source (FDA)


Content licensed under CC BY 4.0